Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03705104
Other study ID # 2018/799
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date December 3, 2019
Est. completion date January 2030

Study information

Verified date April 2024
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this project is to test the effect of an interactive e-health intervention for people with chronic pain.


Description:

Chronic pain conditions are common and difficult to cure. As much as 30% of adults in Norway experience moderate-to-severe chronic pain, i.e., pain having lasted more than 3 months. Chronic pain is also the most common cause of sick leave and disability pension in Norway. Despite a clear request from the authorities, e-health interventions for chronic pain has not yet been tested and implemented. The aim of this study is to investigate the effect of an interactive e-health intervention for people living with chronic pain, using outcome measures such as pain intensity, pain acceptance, anxiety/depression and quality of life. The e-health intervention will first be tested in a pilot study with 50 patients with different pain diagnoses and eventually in a randomized controlled trial with a sample of 240 patients with different pain diagnoses. The intervention will consist of one face-to-face introductory group followed by 9 app-based modules containing cognitive behavioral pain self-management material. The 9 modules will be distributed over minimum 27 days (minimum 3 days per module). The participants in the randomized controlled trial will be randomly assigned to use the e-health intervention or to a treatment as usual control group. Both groups will receive outcome measures to complete at baseline and at 3, 6 and 12 months. Post-RCT, the EPIO study will also include a non-randomized group receiving the app-based EPIO program but without receiving an introduction session and follow up phone calls to examine potential benefits from receiving the app-based program only.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 340
Est. completion date January 2030
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Chronic pain (pain > 3 months) - > 18 years of age - Able to write/read/speak Norwegian - Have their own smart phone, PC or tablet Exclusion Criteria: - Cancer related pain - Migraine

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
EPIO
App for self-management of chronic pain An app consisting of 9 modules focusing on cognitive behavioral pain self-management.

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (11)

Lead Sponsor Collaborator
Oslo University Hospital Diakonhjemmet Hospital, Drammen municipality, Norway, Mayo Clinic, The Research Council of Norway, University College of Southeast Norway, University of Florida, University of Oslo, University of Twente, University of Washington, Vestre Viken Hospital Trust

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Brief Pain Inventory (BPI) (Short Form) - Assessing change 9 item scale measuring pain interference on function. Using this measure, respondents rate their worst, least, average, and current pain intensity and also rate the degree to which pain interferes with 7 domains of functioning (general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life) on a scale of 0 to 10.
There is no scoring algorithm, but "worst pain" or the arithmetic mean of the four severity items can be used as measures of pain severity; the arithmetic mean of the seven interference items can be used as a measure of pain interference.
Baseline, and at 3, 6, and 12 months.
Secondary Pain Catastrophizing Scale (PCS) - Assessing change 13 item scale measuring helplessness, magnification and rumination. Patients rate items on a scale from 0 (not at all) to 4 (all the time). The total score range for the PCS is 0 to 52, with higher scores reflecting higher degrees of catastrophizing. Baseline, and at 3, 6, and 12 months.
Secondary Chronic Pain Acceptance Questionnaire (CPAQ) - Assessing change 8 item scale measuring pain acceptance. It is scored on a 7-point Likert scale (0 = never true; 6 = always true). Higher scores reflect higher acceptance of pain. Baseline, and at 3, 6, and 12 months.
Secondary Self-Regulatory Fatigue 18 (SRF-18) - Assessing change 18 item scale measuring self-regulatory capacity with cognitive, emotional, and behavioral components. Items are scored on a 5-point Likert scale (1 to 5). The obtainable score range is 18 to 90, with higher numbers re?ecting higher SRF. Baseline, and at 3, 6, and 12 months.
Secondary The Hospital Anxiety and Depression Scale (HADS) - Assessing change 14 item scale measuring anxiety and depression. Respondents are asked to indicate which of 4 response options (rated from 0-3; score range, 0-42) comes closest to describing how they have been feeling in the previous week for each item. Scores from 0-7 on the subscales are regarded as being in the normal range; a score of 11 or higher indicates a probable presence of a mood disorder, and a score of 8-10 is suggestive of the presence of the state. Baseline, and at 3, 6, and 12 months.
Secondary System Usability Scale (SUS) 1o item scale measuring usability, with five response options for respondents; from Strongly agree to Strongly disagree. The obtainable score range is 25 to 100. A SUS score above a 68 would be considered above average and anything below 68 is below average. At 3 months
Secondary RAND Health Related Quality of Life - Assessing change 36 item scale measuring health related quality of life. The RAND-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. Baseline, and at 3, 6, and 12 months.
See also
  Status Clinical Trial Phase
Completed NCT03413501 - A Multi-disciplinary Pain Intervention (MUD-PI) for Patients With Chronic Widespread Primary Pain N/A
Completed NCT04674670 - Psychobiological Mechanisms Underlying Chronic Pain N/A
Active, not recruiting NCT03150017 - An Internet-Delivered Pain Management Programme for Spinal Cord Injury Pain N/A
Completed NCT03699007 - GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain N/A
Completed NCT03915938 - Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain Phase 2/Phase 3
Completed NCT05478668 - Predictors of Pain Chronicity in Patients With Gunshot and Mine-explosive Wounds
Recruiting NCT03215940 - Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC) Early Phase 1
Completed NCT03157362 - Effects of Social Presence and Perception in Virtual Reality on Pain N/A
Completed NCT03882333 - Effects of Acute Exercise on Pain and Human Movement N/A
Completed NCT03119896 - Supporting Self-management of Chronic Pain N/A
Withdrawn NCT06416826 - Rhythmic Sensory Stimulation on Fibromyalgia N/A

External Links